Coronary disease & ACSCohort study

Are the ARC-HBR criteria associated with major bleeding and ischaemic events in an all-comer acute myocardial infarction (AMI) population? Insights from the MINAP and SWEDEHEART registries

Eur Heart J Acute Cardiovasc CarePublished

  • national registries

Authors' conclusion

In an all-comer AMI population, one in three meet HBR criteria. HBR patients had significantly higher rates of MACE and major bleeding, persisting whether managed invasively or medically. We show that the ARC-HBR criteria are associated with increased bleeding and MACE risk in all-comer AMI patients.

Study context

Population
AMI patients in England and Wales (E&W) and Sweden between 2005 and 2019AMI patients included from MINAP and SWEDEHEART national registries · E&W (39% high bleeding risk (HBR), median follow-up of 1901 days) 563,251 · Sweden (39% HBR, 2084 days) 189,102
Exposure
Patients were categorized according to the Academic Research Consortium for HBR criteria (ARC-HBR)
Outcome
Adjusted risk of MACE (admission with reinfarction and cardiovascular death) and major bleeding events (death or readmission with bleeding)
Follow-up
Up to 5 years

Main finding

As reported in the abstract

HBR patientsAdjusted hazard ratio (95% CI)P value
MACE, E&W
2.99(2.95–3.02)
P < 0.001
MACE, Sweden
2.68(2.64–2.73)
P < 0.001
major bleeding, E&W
2.28(2.21–2.35)
P < 0.001
major bleeding, Sweden
2.71(2.58–2.85)
P < 0.001

Observational data: associations, not effects.

Secondary outcomes

Major adverse cardiovascular events (MACE), medically and invasively managed patients (secondary analyses)

ComparisonaHR (CI)P value
HBR patients · medically managed, E&W3.24 (3.19–3.29)P < 0.001
HBR patients · medically managed, Sweden2.31 (2.26–2.37)P < 0.001
HBR patients · invasively managed, E&W2.94 (2.88–3.00)P < 0.001
HBR patients · invasively managed, Sweden1.98 (1.92–2.04)P < 0.001

Major bleeding events, medically and invasively managed patients (secondary analyses)

ComparisonaHR (CI)P value
HBR patients · medical, E&W2.28 (2.19–2.37)P < 0.001
HBR patients · medical, Sweden1.35 (1.25–1.45)P < 0.001
HBR patients · invasive, E&W2.25 (2.15–2.35)P < 0.001
HBR patients · invasive, Sweden1.41 (1.29–1.54)P = 0.024

Original publication

Are the ARC-HBR criteria associated with major bleeding and ischaemic events in an all-comer AMI population? Insights from the MINAP and SWEDEHEART registries. Eur Heart J Acute Cardiovasc Care. Published 19 February 2026. doi:10.1093/ehjacc/zuag025

Summarised from the published abstract; every number is checked against it